These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 10315491)
1. Part 1, Defining the hospital product. The response to PPS: inside, outside, over time. Kalison MJ; Averill R Healthc Financ Manage; 1984 Jan; 38(1):78-84, 88. PubMed ID: 10315491 [No Abstract] [Full Text] [Related]
2. Tracking capital costs by product line is key. Riffer J Hospitals; 1986 Jun; 60(12):68. PubMed ID: 3710453 [No Abstract] [Full Text] [Related]
3. Capital payment under PPS: can hospitals still bloom? Nash D; Haught JA; Hopkins A; Oxler K; Rovinsky M Healthc Financ Manage; 1986 Apr; 40(4):29-37. PubMed ID: 10300594 [TBL] [Abstract][Full Text] [Related]
4. A securities analyst views capital cost reimbursement. Gargiulo GT Health Manage Q; 1984; ():6-9. PubMed ID: 10273589 [No Abstract] [Full Text] [Related]
5. Prospective payment for capital: the financial nature of capital allowances. Krystynak LF Healthc Financ Manage; 1983 Oct; 37(10):60-8, 74-6. PubMed ID: 10315440 [No Abstract] [Full Text] [Related]
6. What's the controversy behind capital payment under prospective pricing? Warner G Trustee; 1984 Sep; 37(9):39-40. PubMed ID: 10273576 [No Abstract] [Full Text] [Related]
7. The effect of PPS on Medicare timing differences. Bainbridge MA; Geib DG Healthc Financ Manage; 1983 Sep; 37(9):64, 66, 68. PubMed ID: 10315414 [No Abstract] [Full Text] [Related]
8. Assessing present and future capital expense levels under PPS. Cleverley WO Healthc Financ Manage; 1986 Sep; 40(9):62-72. PubMed ID: 10300940 [TBL] [Abstract][Full Text] [Related]
10. Capital reimbursement and health planning: more than a matter of cost-containment. Abernethy D Health Manage Q; 1984; ():2-5. PubMed ID: 10299739 [No Abstract] [Full Text] [Related]
11. Financial tools in evaluating profit and DRG cost determination. Wilson CN Hosp Pharm; 1984 Oct; 19(10):703-5. PubMed ID: 10273580 [No Abstract] [Full Text] [Related]
12. The future of Medicare capital reimbursement. Teach R Cost Containment; 1985 Sep; 7(18):3-6. PubMed ID: 10300504 [No Abstract] [Full Text] [Related]
13. The debate over capital costs. Robinson ML Healthspan; 1986 Mar; 3(3):15-23. PubMed ID: 10300722 [No Abstract] [Full Text] [Related]
15. Equipment acquisition under prospective pricing. Goodhart M Hosp Cap Finance; 1985; 2(4):7-8. PubMed ID: 10274580 [No Abstract] [Full Text] [Related]
16. Part 4: Responding to PPS. The outside response. Kalison MJ; Averill RF; Webb RJ Healthc Financ Manage; 1984 Apr; 38(4):92-100. PubMed ID: 10315533 [No Abstract] [Full Text] [Related]
17. Managing the intermediate product. Piper LR Nurs Manage; 1985 Mar; 16(3):18-20. PubMed ID: 3844685 [No Abstract] [Full Text] [Related]
18. Part 3, Responding to PPS. How hospital managers should respond to PPS. Averill RF; Kalison MJ; Sparrow DA; Owens TR Healthc Financ Manage; 1984 Mar; 38(3):72-6, 82-6. PubMed ID: 10315520 [No Abstract] [Full Text] [Related]
19. The impact of capital payment options under Medicare prospective payment. An ECRI technology management assessment. J Health Care Technol; 1986; 2(4):231-46. PubMed ID: 10300810 [TBL] [Abstract][Full Text] [Related]
20. Changes in Medicare capital PPS rates and rules. Grimaldi P Healthc Financ Manage; 1992 Dec; 46(12):40-2, 44, 46-7. PubMed ID: 10145723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]